【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 18
2 Introduction 19
2.1 Auto-Immune Diseases Overview 19
3 Products under Development 20
3.1 Auto-Immune Diseases – Pipeline Products by Stage of Development 20
3.2 Auto-Immune Diseases – Pipeline Products by Territory 21
3.3 Auto-Immune Diseases – Pipeline Products by Regulatory Path 22
3.4 Auto-Immune Diseases – Pipeline Products by Estimated Approval Date 23
4 Auto-Immune Diseases – Pipeline Products under Development by Companies 24
4.1 Auto-Immune Diseases Companies – Pipeline Products by Stage of Development 24
4.2 Auto-Immune Diseases – Pipeline Products by Stage of Development 28
5 Auto-Immune Diseases Companies and Product Overview 35
5.1 Adaptive Biotechnologies Corporation Company Overview 35
5.1.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
5.2 Agena Bioscience, Inc Company Overview 36
5.2.1 Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.3 Albert-Ludwigs-Universitat Freiburg Company Overview 37
5.3.1 Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview 37
5.4 Alere Inc. Company Overview 40
5.4.1 Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.5 Amarantus Bioscience Holdings, Inc. Company Overview 43
5.5.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.6 Amdix B.V. Company Overview 46
5.6.1 Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 Analyticon Biotechnologies AG Company Overview 47
5.7.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 47
5.8 apDia n.v. Company Overview 48
5.8.1 apDia n.v. Pipeline Products & Ongoing Clinical Trials Overview 48
5.9 Autoimmune Technologies, LLC Company Overview 49
5.9.1 Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.10 Beckman Coulter, Inc. Company Overview 55
5.10.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.11 BG Medicine, Inc. Company Overview 57
5.11.1 BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.12 Biocortech Company Overview 59
5.12.1 Biocortech Pipeline Products & Ongoing Clinical Trials Overview 59
5.13 Biogen, Inc. Company Overview 60
5.13.1 Biogen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.14 Biomedal S.L. Company Overview 62
5.14.1 Biomedal S.L. Pipeline Products & Ongoing Clinical Trials Overview 62
5.15 Biomerica, Inc. Company Overview 66
5.15.1 Biomerica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.16 Bionure Farma, S.L. Company Overview 70
5.16.1 Bionure Farma, S.L. Pipeline Products & Ongoing Clinical Trials Overview 70
5.17 Bio-Rad Laboratories, Inc. Company Overview 71
5.17.1 Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.18 BioRap Technologies Ltd. Company Overview 73
5.18.1 BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
5.19 Boston University Company Overview 74
5.19.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 74
5.20 CareDx, Inc. Company Overview 75
5.20.1 CareDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.21 CD Diagnostics, Inc. Company Overview 77
5.21.1 CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.22 Chronix Biomedical, Inc. Company Overview 78
5.22.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.23 Co-Diagnostics HBDC, Inc. Company Overview 81
5.23.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.24 Crescendo Bioscience, Inc. Company Overview 82
5.24.1 Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.25 Digna Biotech, S.L. Company Overview 86
5.25.1 Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 86
5.26 Durin Technologies, Inc. Company Overview 90
5.26.1 Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.27 Enterome Bioscience SA Company Overview 91
5.27.1 Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 91
5.28 Ezose Sciences Inc. Company Overview 93
5.28.1 Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.29 Flamentera AG Company Overview 94
5.29.1 Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview 94
5.30 Genalyte, Inc. Company Overview 95
5.30.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.31 Genentech, Inc. Company Overview 96
5.31.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.32 GeNeuro SA Company Overview 99
5.32.1 GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview 99
5.33 Glycominds Ltd. Company Overview 101
5.33.1 Glycominds Ltd. Pipeline Products & Ongoing Clinical Trials Overview 101
5.34 Grifols, S.A. Company Overview 102
5.34.1 Grifols, S.A. Pipeline Products & Ongoing Clinical Trials Overview 102
5.35 Hannover Medical School Company Overview 104
5.35.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 104
5.36 Helmholtz Centre for Infection Research Company Overview 105
5.36.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 105
5.37 HOB Biotech Group Co., Ltd. Company Overview 106
5.37.1 HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 106
5.38 Hospital for Special Surgery Company Overview 107
5.38.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 107
5.39 Hycor Biomedical Inc. Company Overview 108
5.39.1 Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
5.40 Ignyta, Inc. Company Overview 110
5.40.1 Ignyta, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.41 ImmusanT, Inc. Company Overview 114
5.41.1 ImmusanT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114
5.42 Innobiochips Company Overview 115
5.42.1 Innobiochips Pipeline Products & Ongoing Clinical Trials Overview 115
5.43 INOVA Diagnostics, Inc. Company Overview 116
5.43.1 INOVA Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.44 Institut National de la Sante et de la Recherche Medicale Company Overview 126
5.44.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 126
5.45 Is Diagnostics Company Overview 127
5.45.1 Is Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 127
5.46 LineaGen, Inc. Company Overview 128
5.46.1 LineaGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 128
5.47 Lophius Biosciences GmbH Company Overview 129
5.47.1 Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 129
5.48 Louisville Bioscience, Inc. Company Overview 130
5.48.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.49 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview 134
5.49.1 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Pipeline Products & Ongoing Clinical Trials Overview 134
5.50 Medica Corporation Company Overview 135
5.50.1 Medica Corporation Pipeline Products & Ongoing Clinical Trials Overview 135
5.51 Metabolomic Technologies Inc. Company Overview 138
5.51.1 Metabolomic Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 Metanomics Health GmbH Company Overview 142
5.52.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 142
5.53 MSDx, Inc. Company Overview 143
5.53.1 MSDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 143
5.54 Myriad Genetics, Inc. Company Overview 147
5.54.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.55 Nanosphere, Inc. Company Overview 149
5.55.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149
5.56 Neuro Vigor, LLC Company Overview 151
5.56.1 Neuro Vigor, LLC Pipeline Products & Ongoing Clinical Trials Overview 151
5.57 Northwestern University Company Overview 152
5.57.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 152
5.58 NoToPharm s.r.l. Company Overview 154
5.58.1 NoToPharm s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 154
5.59 NOWDiagnostics Company Overview 162
5.59.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 162
5.60 OmniBiome Therapeutics Inc. Company Overview 163
5.60.1 OmniBiome Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 163
5.61 One Way Liver Genomics, S.L. Company Overview 164
5.61.1 One Way Liver Genomics, S.L. Pipeline Products & Ongoing Clinical Trials Overview 164
5.62 OPKO Health, Inc. Company Overview 166
5.62.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.63 Oxford Gene Technology Limited Company Overview 168
5.63.1 Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 168
5.64 Oxford Immunotec Limited Company Overview 169
5.64.1 Oxford Immunotec Limited Pipeline Products & Ongoing Clinical Trials Overview 169
5.65 Pediatric Bioscience, LLC Company Overview 170
5.65.1 Pediatric Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 170
5.66 Progentec Diagnostics, Inc. Company Overview 171
5.66.1 Progentec Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.67 Protagen AG Company Overview 172
5.67.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 172
5.68 ProteinLogic Ltd Company Overview 182
5.68.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 182
5.69 Quanterix Corporation Company Overview 183
5.69.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 183
5.70 Regulus Therapeutics Inc. Company Overview 184
5.70.1 Regulus Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.71 Rice University Company Overview 186
5.71.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 186
5.72 Roche Diagnostics International Ltd. Company Overview 187
5.72.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 187
5.73 Shuwen Biotech Co. Ltd. Company Overview 193
5.73.1 Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 193
5.74 Singulex, Inc. Company Overview 194
5.74.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 194
5.75 SomaLogic, Inc. Company Overview 195
5.75.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 195
5.76 Southern Illinois University Carbondale Company Overview 196
5.76.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 196
5.77 SQI Diagnostics Inc. Company Overview 198
5.77.1 SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 198
5.78 The Johns Hopkins University Company Overview 207
5.78.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 207
5.79 The Walter and Eliza Hall Institute of Medical Research Company Overview 210
5.79.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 210
5.80 TheraDiag SA Company Overview 211
5.80.1 TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview 211
5.81 Thermo Fisher Scientific Inc. Company Overview 213
5.81.1 Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 213
5.82 Toscana Biomarkers Srl Company Overview 237
5.82.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 237
5.83 Univalue Valorizacion, S.L. Company Overview 243
5.83.1 Univalue Valorizacion, S.L. Pipeline Products & Ongoing Clinical Trials Overview 243
5.84 University of California, San Francisco Company Overview 244
5.84.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 244
5.85 University of Chicago Company Overview 247
5.85.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 247
5.86 University of Colorado Company Overview 248
5.86.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 248
5.87 University of Florida Company Overview 249
5.87.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 249
5.88 University of Manchester Company Overview 250
5.88.1 University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 250
5.89 University of Oxford Company Overview 252
5.89.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 252
5.90 University of Pecs Company Overview 256
5.90.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 256
5.91 University Rovira i Virgili Company Overview 257
5.91.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 257
5.92 US Biomarkers, Inc. Company Overview 258
5.92.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 258
5.93 Washington University in St. Louis Company Overview 259
5.93.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 259
5.94 XAir Diagnostics B.V. Company Overview 260
5.94.1 XAir Diagnostics B.V. Pipeline Products & Ongoing Clinical Trials Overview 260
5.95 XEPTAGEN SpA Company Overview 261
5.95.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 261
5.96 Yale University Company Overview 262
5.96.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 262
6 Auto-Immune Diseases- Recent Developments 263
7 Appendix 292
7.1 Methodology 292
7.2 About GlobalData 294
7.3 Contact Us 295
7.4 Disclaimer 295
【レポート販売概要】
■ タイトル：世界の自己免疫疾患用装置開発動向：医療機器パイプライン分析2015■ 英文：Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0148EPD
■ 調査対象地域：グローバル
- 9-デカン酸メチルエステルの世界市場分析：用途別（香味料･香料、医薬品）、セグメント予測The global 9-decanoic acid methyl ester market is expected to reach USD 240.0 million by 2025, according to a new report by Grand View Research, Inc. Rising awareness regarding the use of green chemicals coupled with rapidly growing demand for esters in flavors & fragrances industry is likely to boost 9-decanoic acid methyl ester consumption in upcoming years. The increasing number of biorefinerie …
- エアロスタット・システム（軽航空機/気球）のグローバル市場This report discusses the market opportunities in the aerostat systems market. This market has huge potential due to its various applications in the homeland security and defense segments. Aerostat is a lighter-than-air platform that consists of an aerodynamic balloon tethered to the ground cables. The cables act as a relay for data transmission between the aerostat and ground station. The aerosta …
- 世界のヘアケア市場のM&A動向（2014年6月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global haircare market during June 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global haircare market throughout the month. Additionally, the report provides an overview of all the partnerin …
- 産業用制御およびファクトリーオートメーションの世界市場予測（～2024年）“The industrial control and factory automation industrial control and factory automation market to exhibit significant growth from 2018 to 2024”The industrial control and factory automation market is expected to grow from USD 160.0 billion in 2018 to USD 269.5 billion by 2024, at a CAGR of 9.08%. The growth of this market can be attributed to the the increasing use of enabling technologies in manu …
- グローバル可塑剤市場：Global Plasticizer Market 2014-2018TechNavio's analysts forecast the Global Plasticizer market to grow at a CAGR of 5.95 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in demand from the Medical industry. The Global Plasticizer market has also been witnessing the growth in environmental concern. However, the health risks associated with plasticizers could pose a challeng …
- 腫瘍治療薬の日本市場：化学療法、標的療法、免疫療法、ホルモン療法The Japan oncology drugs market accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026. Cancer is a serious medical condition marked by the presence of tumor cells present in the body. The formation of tumor cells take place when the normal cells grow at an abnormal rate. Moreover, these tumor cells also have the ability …
- WiFi対応のLTEスモールセルゲートウェイ予測2013-2020（WiFi Enabled LTE Small Cell Gateway Forecasts: 2013 ～2020）Driven by large scale LTE investments and the high penetration of embedded WiFi capability in consumer electronic devices, both fixed and mobile, a number of wireless carriers are taking a keen interest in WiFi enabled LTE gateways. A WiFi enabled LTE small cell gateway (or base station) is an emerging network element, which has an LTE interface towards the carrier network and a WiFi interface tow …
- 世界の軍事用電子光学/赤外線（EO/IR）市場（2014-2024）Product Synopsis This report is the result of SDI's extensive market and company research covering the global military EO/IR Systems industry. It provides detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of the leading companies in the industry, and key news. Introduction and Landscape Why wa …
- 建設産業用テレハンドラーの世界市場ABSTRACTAbout Telehandlers Market for Construction Industry A telehandler, also called a telescopic handler, is a machine that is used to lift loads in agricultural, construction, environment, logistics, and mining and quarrying industries. Apart from lifting loads, this machine can be used for material handling, digging trenches, and elevating personnel and underground mine baskets. Technavio’s a …
- 機内エンターテインメント（IFE）の世界市場予測（～2022）The inflight entertainment (IFE) market is projected to grow from an estimated USD 3.18 Billion in 2016 to USD 6.91 Billion by 2022, at a CAGR of 13.80% during the forecast period. Enhancing passenger experience, new technology development, and major source of ancillary revenue for airlines through inflight entertainment (IFE) are key factors expected to drive the inflight entertainment (IFE) mark …
- Home Automation: Solutions and Suppliers 2010Home Automation is the automatic control of a home's electronic systems, such as security, heating and air conditioning, entertainment, and lighting. A home automation system is one in which these systems are integrated into one, easy-to-use system. The purpose of a home automation system is to enable residents to perform normal daily tasks in a simpler manner. A home automation system will use sc …
- 世界の運動用フットウェア市場動向（2012-2016）TechNavio's analysts forecast the Global Athletic Footwear market to grow at a CAGR of 1.75 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for comfortable footwear. The Global Athletic Footwear market has also been witnessing the increasing demand for lightweight athletic shoes. However, the increasing availability of counterfe …
- Boston Scientific Corporation：市場シェア分析Boston Scientific Corporation Market Share Analysis Summary GlobalData’s new report, “Boston Scientific Corporation Market Share Analysis” provides in-depth information on Boston Scientific Corporation’s market position in the different medical equipment markets it operates in. The report provides Boston Scientific Corporation market share information in six key market categories – Remote Patient …
- 世界のトップ10分析技術市場“Growing volume and variety of business data across industry verticals is expected to drive the growth of the analytics technologies market during the forecast period”The top 10 analytics technologies market is expected to grow at a significant rate during the forecast period. This report covers the major analytics technologies such as analytics as a Service, streaming analytics, edge analytics, D …
- 成人型呼吸促迫症候群（ARDS）：治療薬のグローバル治験動向（2014年下半期）Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Adult Respiratory Distress Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adult Respiratory Distress Syndro …
